Efnisyfirlit

• COVER PAGE
• TITLE PAGE
• COPYRIGHT PAGE
• INTRODUCTION
• THE TWO PRIMARY FORMATS OF MEMORY
• THE PROCESSING OPERATIONS
• TRADITIONAL MEMORY MODELS
• THE BIOLOGICAL BASIS OF MEMORY
• MEMORY DYSFUNCTIONS
• AIMS AND ORGANISATION OF THIS BOOK
• ACKNOWLEDGEMENTS
• PART I: NEUROPSYCHOLOGY AND PHARMACOLOGY OF MEMORY
• 1. WHAT IS MEMORY?
• INTRODUCTION
• SOME CONCEPTS OF MEMORY
• DECLARATIVE MEMORY
• PROCEDURAL MEMORY
• EMOTIONAL MEMORY
• RETRIEVAL-INDUCED FORGETTING
• MEMORY IN CHILDREN AND THE ELDERLY
• DISCUSSION
• 2. NEUROPSYCHOLOGICAL ASSESSMENT OF MEMORY
• INTRODUCTION
• TESTS AS DIAGNOSTIC TOOLS
• MEMORY ASSESSMENT BATTERIES
• INDIVIDUAL MEMORY TESTS
• METAMEMORY
• DISCUSSION
• 3. NEUROLOGICAL ASSESSMENT OF MEMORY
• INTRODUCTION
• MEDIAL TEMPORAL LOBE SYSTEM
• BASAL FOREBRAIN
• DIENCEPHALON
• FRONTAL LOBES AND PREFRONTAL CORTEX
• CEREBELLUM AND CEREBELLAR CORTEX
• THE IMPACT OF IMAGING TECHNOLOGY
• DISCUSSION
• 4. PHYSIOLOGICAL AND PHARMACOLOGICAL ASSESSMENT OF MEMORY
• INTRODUCTION
• MONOAMINERGIC RECEPTORS
• CHOLINERGIC RECEPTORS
• GLUTAMATE RECEPTORS
• GABAERGIC RECEPTORS
• NEUROSTEROID AND PEPTIDE RECEPTORS
• PROTEIN KINASES, GENE TRANSCRIPTION, AND PROTEIN SYNTHESIS
• DISCUSSION
• 5. DRUG-INDUCED MEMORY ALTERATION
• INTRODUCTION
• BENZODIAZEPINES
• BARBITURATES
• ANTICHOLINERGICS
• BETA-BLOCKERS AND ALPHA-2 AGONISTS
• CORTICOSTEROIDS
• METHYLENEDIOXYMETHAMPHETAMINE
• ETHANOL
• CAFFEINE
• DISCUSSION
• PART II: PATHOLOGY OF MEMORY
• 6. MEMORY DYSFUNCTIONS
• INTRODUCTION
• FORGETTING
• PARAMNESIA
• AMNESIA
• REPRESSION AND DISSOCIATION
• PERSISTENCE AND INTRUSIVE RECOLLECTIONS
• DISCUSSION
• 7. AGEING AND MEMORY IMPAIRMENT
• INTRODUCTION
• NORMAL AGEING
• AGE-ASSOCIATED MEMORY IMPAIRMENT
• AGEING-ASSOCIATED COGNITIVE DECLINE
• MILD COGNITIVE IMPAIRMENT
• MAINTAINING COGNITIVE VITALITY WITH AGEING
• DISCUSSION
• 8. MEMORY DYSFUNCTIONS IN NEURODEGENERATIVE DISEASES
• INTRODUCTION
• ALZHEIMER’S DISEASE
• SEMANTIC DEMENTIA
• PARKINSON’S DISEASE
• HUNTINGTON’S DISEASE
• DISCUSSION
• 9. MEMORY DYSFUNCTIONS IN NEUROGENIC COMMUNICATION DISORDERS
• INTRODUCTION
• APHASIA
• RIGHT HEMISPHERE DISORDERS
• TRAUMATIC BRAIN INJURY
• DISCUSSION
• 10. MEMORY DYSFUNCTIONS IN PSYCHIATRIC DISEASES
• INTRODUCTION
• SCHIZOPHRENIA
• ANXIETY
• DEPRESSION
• ATTENTION DEFICIT HYPERACTIVITY DISORDER
• DISCUSSION
• 11. Treatments
• INTRODUCION
• PHARMACOLOGICAL TREATMENT
• BEHAVIOURAL TREATMENT
• NERVE STIMULATION TREATMENT
• DISCUSSION
• 12. CONCLUSION
• DISCUSSION AND CONCLUSION
• FUTURE PERSPECTIVE
• REFERENCES